Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Future Oncology (London, England)|July 5, 2022
Lorlatinib as a treatment for ALK-positive lung cancerKeisuke Baba, Yasushi Goto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 27, 2023
[Therapeutic Strategies Targeting HER2 for Gastric Cancer]Keisuke Baba, Narikazu Boku
International Journal of Molecular Sciences|August 21, 2019
Simultaneous Detection of the T790M and L858R Mutations in the EGFR Gene by Oligoribonucleotide Interference-PCRKeisuke Baba, Toshitsugu Fujita, Sadatomo Tasaka, et al.
Frontiers in Oncology|July 3, 2023
Case report: Irinotecan-induced interstitial lung disease in an advanced colorectal cancer patient resurfacing decades after allogeneic bone marrow transplantation for aplastic anemia; a case report and narrative review of literatureKeisuke Baba, Yasuo Matsubara, Yoshihiro Hirata, et al.
Case Reports in Oncology|May 7, 2025
Reinfusion of Malignant Ascites through an Extracorporeal Peritoneal Venous Shunt to Avoid Complications and Assess the Safety of a Denver Shunt: A Case ReportKeisuke Baba, Tomoki Tanie, Yasuo Matsubara, et al.
Asia Pacific Journal of Clinical Nutrition|November 19, 2011
Red meat intake may increase the risk of colon cancer in Japanese, a population with relatively low red meat consumptionRibeka Takachi, Yoshitaka Tsubono, Keisuke Baba, et al.
Internal Medicine (Tokyo, Japan)|September 10, 2023
Prevalence of Drug Fever among Cases of Nosocomial Fever: A Systematic Review and Meta-analysisHidehiro Someko, Yuuji Okazaki, Yasutaka Kuniyoshi, et al.
Oncotargets and Therapy|November 26, 2024
Concentrations of Irinotecan and SN-38 in the Ascites and the Fluid Product of Cell-Free and Concentrated Ascites Reinfusion Therapy 9 Days After Administration of Irinotecan in a Patient with Gastric Cancer: A Case ReportKeisuke Baba, Tomoki Tanie, Yasuo Matsubara, et al.
Thoracic Cancer|January 3, 2019
Efficacy of pembrolizumab for patients with both high PD-L1 expression and an MET exon 14 skipping mutation: A case reportKeisuke Baba, Hisashi Tanaka, Hiroaki Sakamoto, et al.
Medical Oncology (Northwood, London, England)|February 10, 2018
A phase I study of afatinib for patients aged 75 or older with advanced non-small cell lung cancer harboring EGFR mutationsHisashi Tanaka, Kageaki Taima, Yoshihito Tanaka, et al.
Pageof 2